Most trials of statins and CVD outcomes
tested specific doses of statins
against placebo or other statins, rather
than aiming for specific LDL cholesterol
goals (41). In light of this fact, the 2015
ADA Standards of Care have been revised
to recommend when to initiate and intensify
statin therapy (high versus moderate)
based on risk profile (Table 8.1).
The American College of Cardiology/
American Heart Association new Pooled
Cohort Equation, the “Risk Calculator,”
may be a useful tool to estimate 10-
year atherosclerotic CVD (http://my
.americanheart.org). Since diabetes itself
confers increased risk for CVD, the
Risk Calculator has limited use for assessing
risk in individuals with diabetes.
The following recommendations are